[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Liposomes Drug Delivery Market Research Report 2012-2024

July 2019 | 92 pages | ID: G3B0EC2044EEN
HeyReport

US$ 2,820.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.

The global Liposomes Drug Delivery market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
  • Liposomal doxorubicin
  • Liposomal Amphoteracin B
  • Liposomal Paclitaxel
  • Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
  • Johnson & Johnson
  • Gilead Sciences
  • Luye Pharma
  • Sun Pharmaceutical
  • Pacira
  • Fudan-Zhangjiang
  • Sigma-Tau Group
  • Teva Pharmaceutical
  • CSPC
  • Novartis
  • Crucell
  • Celsion Corporation
  • Kingond Pharm
  • Shanghai New Asia
  • Spectrum Pharmaceuticals
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
  • Fungal Infection Therapy
  • Cancer Therapy ( Tumor therapy)
  • Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 MARKET OVERVIEW

1.1 Objectives of Research
  1.1.1 Definition
  1.1.2 Specifications
1.2 Market Segment
  1.2.1 by Type
    1.2.1.1 Liposomal doxorubicin
    1.2.1.2 Liposomal Amphoteracin B
    1.2.1.3 Liposomal Paclitaxel
    1.2.1.4 Others
  1.2.2 by Application
    1.2.2.1 Fungal Infection Therapy
    1.2.2.2 Cancer Therapy ( Tumor therapy)
    1.2.2.3 Others
  1.2.3 by Regions

2 INDUSTRY CHAIN

2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
  2.3.1 SWOT
  2.3.2 Dynamics

3 ENVIRONMENTAL ANALYSIS

3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry

4 MARKET SEGMENTATION BY TYPE

4.1 Market Size
  4.1.1 Liposomal doxorubicin Market, 2013-2018
  4.1.2 Liposomal Amphoteracin B Market, 2013-2018
  4.1.3 Liposomal Paclitaxel Market, 2013-2018
  4.1.4 Others Market, 2013-2018
4.2 Market Forecast
  4.2.1 Liposomal doxorubicin Market Forecast, 2019-2024
  4.2.2 Liposomal Amphoteracin B Market Forecast, 2019-2024
  4.2.3 Liposomal Paclitaxel Market Forecast, 2019-2024
  4.2.4 Others Market Forecast, 2019-2024

5 MARKET SEGMENTATION BY APPLICATION

5.1 Market Size
  5.1.1 Fungal Infection Therapy Market, 2013-2018
  5.1.2 Cancer Therapy ( Tumor therapy) Market, 2013-2018
  5.1.3 Others Market, 2013-2018
5.2 Market Forecast
  5.2.1 Fungal Infection Therapy Market Forecast, 2019-2024
  5.2.2 Cancer Therapy ( Tumor therapy) Market Forecast, 2019-2024
  5.2.3 Others Market Forecast, 2019-2024

6 MARKET SEGMENTATION BY REGION

6.1 Market Size
  6.1.1 Asia-Pacific
    6.1.1.1 Asia-Pacific Market, 2012-2018
    6.1.1.2 Asia-Pacific Market by Type
    6.1.1.3 Asia-Pacific Market by Application
  6.1.2 North America
    6.1.2.1 North America Market, 2012-2018
    6.1.2.2 North America Market by Type
    6.1.2.3 North America Market by Application
  6.1.3 Europe
    6.1.3.1 Europe Market, 2012-2018
    6.1.3.2 Europe Market by Type
    6.1.3.3 Europe Market by Application
  6.1.4 South America
    6.1.4.1 South America Market, 2012-2018
    6.1.4.2 South America Market by Type
    6.1.4.3 South America Market by Application
  6.1.5 Middle East & Africa
    6.1.5.1 Middle East & Africa Market, 2012-2018
    6.1.5.2 Middle East & Africa Market by Type
    6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
  6.2.1 Asia-Pacific Market Forecast, 2019-2024
  6.2.2 North America Market Forecast, 2019-2024
  6.2.3 Europe Market Forecast, 2019-2024
  6.2.4 South America Market Forecast, 2019-2024
  6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 MARKET COMPETITIVE

7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel

8 MAJOR VENDORS

8.1 Johnson & Johnson
8.2 Gilead Sciences
8.3 Luye Pharma
8.4 Sun Pharmaceutical
8.5 Pacira
8.6 Fudan-Zhangjiang
8.7 Sigma-Tau Group
8.8 Teva Pharmaceutical
8.9 CSPC
8.10 Novartis
8.11 Crucell
8.12 Celsion Corporation
8.13 Kingond Pharm
8.14 Shanghai New Asia
8.15 Spectrum Pharmaceuticals

9 CONCLUSION

LIST OF TABLES

Table Product Specifications of Liposomes Drug Delivery
Table Products Segment of Liposomes Drug Delivery
Table Liposomal doxorubicin Overview
Table Liposomal Amphoteracin B Overview
Table Liposomal Paclitaxel Overview
Table Others Overview
Table Global Liposomes Drug Delivery Market by Type, 2011-2022 (USD Million)
Table Application Segment of Liposomes Drug Delivery
Table Fungal Infection Therapy Overview
Table Cancer Therapy ( Tumor therapy) Overview
Table Others Overview
Table Global Liposomes Drug Delivery Market by Application, 2011-2022 (USD Million)
Table Global Liposomes Drug Delivery Market by Region, 2011-2022 (USD Million)
Table Cost of Liposomes Drug Delivery
Table Market Dynamics
Table Policy of Liposomes Drug Delivery
Table GDP of Major Countries
Table Liposomal doxorubicin CAGR by Revenue and Volume, 2012-2018
Table Liposomal Amphoteracin B CAGR by Revenue and Volume, 2012-2018
Table Liposomal Paclitaxel CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Liposomal doxorubicin CAGR by Revenue and Volume, 2012-2024
Table Liposomal Amphoteracin B CAGR by Revenue and Volume, 2012-2024
Table Liposomal Paclitaxel CAGR by Revenue and Volume, 2012-2024
Table Others CAGR by Revenue and Volume, 2012-2024
Table Fungal Infection Therapy CAGR by Revenue and Volume, 2012-2018
Table Cancer Therapy ( Tumor therapy) CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Global Liposomes Drug Delivery Market by Vendors, 2012-2018 (USD Million)
Table Global Liposomes Drug Delivery Market by Vendors, 2012-2018 (in Volume)
Table Global Liposomes Drug Delivery Market Share by Vendors, 2012-2018 (USD Million)
Table Global Liposomes Drug Delivery Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Johnson & Johnson Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Sciences Profile List
Table Microecological Modulator Operating Data of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Luye Pharma Profile List
Table Microecological Modulator Operating Data of Luye Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sun Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Sun Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pacira Profile List
Table Microecological Modulator Operating Data of Pacira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Fudan-Zhangjiang Profile List
Table Microecological Modulator Operating Data of Fudan-Zhangjiang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sigma-Tau Group Profile List
Table Microecological Modulator Operating Data of Sigma-Tau Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CSPC Profile List
Table Microecological Modulator Operating Data of CSPC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Crucell Profile List
Table Microecological Modulator Operating Data of Crucell (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celsion Corporation Profile List
Table Microecological Modulator Operating Data of Celsion Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kingond Pharm Profile List
Table Microecological Modulator Operating Data of Kingond Pharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shanghai New Asia Profile List
Table Microecological Modulator Operating Data of Shanghai New Asia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Spectrum Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Spectrum Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

LIST OF FIGURES

Figure Liposomes Drug Delivery Picture
Figure Industry Chain Structure of Liposomes Drug Delivery
Figure SWOT of Liposomes Drug Delivery
Figure Liposomal doxorubicin Market Size and Growth, 2012-2018 (USD Million)
Figure Liposomal doxorubicin Market Size and Growth, 2012-2018 (in Volume)
Figure Liposomal Amphoteracin B Market Size and Growth, 2012-2018 (USD Million)
Figure Liposomal Amphoteracin B Market Size and Growth, 2012-2018 (in Volume)
Figure Liposomal Paclitaxel Market Size and Growth, 2012-2018 (USD Million)
Figure Liposomal Paclitaxel Market Size and Growth, 2012-2018 (in Volume)
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Others Market Size and Growth, 2012-2018 (in Volume)
Figure Liposomal doxorubicin Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Liposomal doxorubicin Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Liposomal Amphoteracin B Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Liposomal Amphoteracin B Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Liposomal Paclitaxel Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Liposomal Paclitaxel Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Others Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Others Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Fungal Infection Therapy Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Cancer Therapy ( Tumor therapy) Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Liposomes Drug Delivery Market Concentration by Region
Figure Marketing Channels Overview


More Publications